Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Closed Research Teams
  • View item
  • Home
  • ICR Divisions
  • Closed Research Teams
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT

Thumbnail
View/Open
Published version (286.6Kb)
Date
2011-06-28
ICR Author
Hopwood, P
Author
Challberg, J
Ashcroft, L
Lalloo, F
Eckersley, B
Clayton, R
Hopwood, P
Selby, P
Howell, A
Evans, DG
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
BACKGROUND: Women at high ovarian cancer risk, especially those with mutations in BRCA1/BRCA2, are encouraged to undergo bilateral risk-reducing salpingo-oophorectomy (BRRSPO) prior to the natural menopause. The decision to use HRT to cover the period of oestrogen deprivation up to 50 years of age is difficult because of balancing the considerations of breast cancer risk, bone and cardiovascular health. METHODS: We reviewed by questionnaire 289 women after BRRSPO aged <= 48 years because of high ovarian cancer risk; 212 (73%) of women responded. RESULTS: Previous HRT users (n = 67) had significantly worse endocrine symptom scores than 67 current users (P = 0.006). A total of 123 (58%) of women had >= 24 months of oestrogen deprivation <50 years with 78 (37%) never taking HRT. Bone density (DXA) evaluations were available on 119 (56%) women: bone loss with a T score of <=-1.0 was present in 5 out of 31 (16%) women with no period of oestrogen deprivation <50 years compared with 37 out of 78 (47%) of those with >= 24 months of oestrogen deprivation (P = 0.03). INTERPRETATION: Women undergoing BRRSPO <50 years should be counselled concerning the risks/benefits of HRT, taking into consideration the benefits on symptoms, bone health and cardiovascular health, and that the risks of breast cancer from oestrogen-only HRT appear to be relatively small. British Journal of Cancer (2011) 105, 22-27. doi:10.1038/bjc.2011.202 www.bjcancer.com Published online 7 June 2011 (C) 2011 Cancer Research UK
URI
https://repository.icr.ac.uk/handle/internal/2326
DOI
https://doi.org/10.1038/bjc.2011.202
Collections
  • Closed Research Teams
Research team
Psychology Research Group
Language
eng
License start date
2011-06-28
Citation
BRITISH JOURNAL OF CANCER, 2011, 105 pp. 22 - 27
Publisher
NATURE PUBLISHING GROUP

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.